217
Participants
Start Date
September 30, 2012
Primary Completion Date
December 31, 2012
Study Completion Date
December 31, 2012
BD NEXT 31G x 5 mm pen needle
Each pen needle type will be used for approximately one week. Subjects will use their current pen injector device.
BD NEXT 31G x 8mm pen needle
Each pen needle type will be used for approximately one week. Subjects will use their current pen injector device.
BD NEXT 32G x 4mm pen needle
Each pen needle type will be used for approximately one week. Subjects will use their current pen injector device.
Corporation Lane Internal Medicine and Research Center, Virginia Beach
Mountain Diabetes and Endocrine Center, Asheville
Holston Medical Group, Kingsport
Physicians Research Center, Toms River
LMC Endocrinology Center, Toronto
Lead Sponsor
Becton, Dickinson and Company
INDUSTRY